Founded Date: 2016-01-01
Last Funding Type: Series B
Headquarters: Los Angeles, California, United States
Investors Number: 18
Technology: Rare Genetic Disorders
Industry: Early Drug Development
Last Funding Date: 2022-11-28
Funding Status: Early Stage Venture
Total Funding: 63200000